Avid Radiopharmaceuticals, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$12.0M
Doctors Paid
111
Transactions
676
2024 Total
$844,411
Payment Breakdown by Category
Research$11.6M (96.8%)
Consulting$344,197 (2.9%)
Travel$33,419 (0.3%)
Food & Beverage$5,978 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $11.6M | 477 | 96.8% |
| Consulting Fee | $344,197 | 53 | 2.9% |
| Travel and Lodging | $33,419 | 41 | 0.3% |
| Food and Beverage | $5,978 | 105 | 0.0% |
Payments by Type
Research
$11.6M
477 transactions
General
$383,594
199 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A CLINICO-PATHOLOGICAL STUDY OF THE CORRESPONDENCE BETWEEN 18F-AV-1451 PET IMAGING AND POST-MORTEM ASSESSMENT OF TAU PATHOLOGY | $1.9M | 4 | 75 |
| REGISTRY OF AMYLOID POSITIVE PATIENTS FOR ALZHEIMER'S DISEASE DRUG RESEARCH TRIALS | $1.8M | 5 | 193 |
| A MULTICENTER SCREENING STUDY WITH FLORTAUCIPIR F 18 IN PATIENTS WITH EARLY SYMPTOMATIC AD | $1.7M | 0 | 22 |
| A PHASE II-III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTI-CENTER STUDY OF 2 POTENTIAL DISEASE MODIFYING THERAPIES IN INDIVIDUALS AT RISK FOR AND WITH DOMINANTLY INHERITED ALZHEIMER DISEASE | $1.3M | 0 | 4 |
| AN OPEN LABEL, MULTICENTER STUDY, EVALUATING THE SAFETY AND IMAGING CHARACTERISTICS OF 18F-AV-1451 IN COGNITIVELY HEALTHY VOLUNTEERS, SUBJECTS WITH MILD COGNITIVE IMPAIRMENT, AND SUBJECTS WITH ALZHEIMERS DISEASE | $1.3M | 0 | 56 |
| H7I-AV-S029 | $733,014 | 1 | 4 |
| BIOSPECIMEN COLLECTION FOR NEURODEGENERATION BIOMARKER RESEARCH AND ASSAY DEVELOPMENT | $671,941 | 0 | 2 |
| AN OPEN LABEL, MULTICENTER STUDY EVALUATING THE IMAGING CHARACTERISTICS OF A FOLLOW UP 18F-AV-1451 SCAN IN SUBJECTS THAT PARTICIPATED IN THE CONFIRMATORY COHORT OF 18F-AV-1451-A05 | $646,271 | 16 | 71 |
| AMYLOID ACCUMULATION IN PRE-CLINICAL AND EARLY CLINICAL AD | $542,025 | 0 | 3 |
| 18F-AV-1451 PET IMAGING IN SUBJECTS WITH FRONTOTEMPORAL DEMENTIA | $190,107 | 0 | 9 |
| BLOOD SAMPLE COLLECTION FOR ANALYTICAL VALIDATION OF PLASMA P-TAU217 ASSAY | $170,830 | 0 | 4 |
| EVALUATION OF FLORTAUCIPIR PET SIGNAL AND COGNITIVE CHANGE IN EARLY ALZHEIMER'S DISEASE | $143,500 | 9 | 9 |
| THIS STUDY WILL EVALUATE 18F-AV-1451 FOR BRAIN IMAGING OF TAU IN SUBJECTS WITH PROGRESSIVE SUPRANUCLEAR PALSY -PSP-, CORTICOBASAL DEGENERATION -CBD- AND HEALTHY VOLUNTEERS | $105,211 | 0 | 5 |
| 18F-AV-1451 PET IMAGING IN PROFESSIONAL FIGHTERS | $95,147 | 0 | 2 |
| AN OPEN LABEL, MULTICENTER STUDY, EVALUATING THE IMAGING CHARACTERISTICS OF A FOLLOW-UP 18F-AV-1451 SCAN IN SUBJECTS WHO HAVE HAD A PRIOR 18F-AV-1451 SCAN | $80,360 | 3 | 5 |
| CLINICAL EVALUATION OF FLORBETAPIR F 18 - 18F-AV-45 | $37,561 | 0 | 7 |
| A READER STUDY TO ASSESS ACCURACY AND RELIABILITY OF FLORTAUCIPIR F 18 PET SCAN INTERPRETATION | $23,000 | 1 | 1 |
| 18F-AV-1451 AND FLORBETAPIR F 18 PET IMAGING IN SUBJECTS WITH REPETITIVE BRAIN TRAUMA AT HIGH RISK FOR CHRONIC TRAUMATIC ENCEPHALOPATHY | $7,177 | 0 | 1 |
| CLINICAL EVALUATION OF 18F-AV-1451 | $6,385 | 0 | 1 |
| AN OPEN LABEL, MULTICENTER STUDY, EVALUATING THE SAFETY AND EFFICACY OF 18F-AV-133 PET IMAGING TO IDENTIFY SUBJECTS WITH DOPAMINERGIC DEGENERATION AMONG SUBJECTS PRESENTING TO A MOVEMENT DISORDERS SPECIALTY CLINIC WITH AN UNCERTAIN DIAGNOSIS | $2,800 | 0 | 1 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Diagnostic Radiology | $291,380 | 21 | $13,875 |
| Nuclear Radiology | $154,272 | 11 | $14,025 |
| Internal Medicine | $74,378 | 6 | $12,396 |
| Endocrinology, Diabetes & Metabolism | $55,025 | 1 | $55,025 |
| Specialist | $48,986 | 2 | $24,493 |
| Nuclear Medicine | $47,490 | 7 | $6,784 |
| Neuroradiology | $46,959 | 3 | $15,653 |
| Psychiatry | $43,322 | 5 | $8,664 |
| Neurology | $31,954 | 29 | $1,102 |
| Anatomic Pathology & Clinical Pathology | $28,192 | 1 | $28,192 |
| Family Medicine | $19,929 | 3 | $6,643 |
| Nuclear Imaging & Therapy | $4,774 | 2 | $2,387 |
| Nuclear Cardiology | $575.00 | 1 | $575.00 |
| Clinical Neurophysiology | $278.55 | 1 | $278.55 |
| Family | $172.29 | 3 | $57.43 |
| Student in an Organized Health Care Education/Training Program | $145.30 | 6 | $24.22 |
| Nephrology | $99.68 | 1 | $99.68 |
| Behavioral Neurology & Neuropsychiatry | $45.49 | 1 | $45.49 |
| Neurological Surgery | $36.73 | 1 | $36.73 |
| Physician Assistant | $30.31 | 2 | $15.16 |
| Vascular & Interventional Radiology | $24.33 | 1 | $24.33 |
| Ophthalmology | $23.65 | 1 | $23.65 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Kevin Weber, M.d, M.D | Diagnostic Radiology | Cincinnati, OH | $92,189 | $0 |
| Dr. Robert Falcone, M.d, M.D | Internal Medicine | Whitehouse Station, NJ | $71,125 | $0 |
| Dr. Joseph Sam, M.d, M.D | Diagnostic Radiology | Tacoma, WA | $65,298 | $0 |
| Rajan Agarwal, Md, MD | Nuclear Radiology | Abington, PA | $64,000 | $0 |
| Dr. Kristina Utzschneider, Md, MD | Endocrinology, Diabetes & Metabolism | Seattle, WA | $55,025 | $0 |
| Dr. Val Liberace, M.d, M.D | Diagnostic Radiology | Harrisonburg, VA | $51,944 | $0 |
| Dr. Vijay Viswanathan, M.d, M.D | Neuroradiology | Dover, DE | $46,653 | $0 |
| Dr. Ernest Depuey, M.d, M.D | Nuclear Medicine | New York, NY | $38,777 | $0 |
| Dr. Jack Klapper, Md, MD | Specialist | Denver, CO | $34,674 | $0 |
| John Edmunds, Md, Phd, MD, PHD | Diagnostic Radiology | Greensboro, NC | $34,048 | $0 |
| Unknown Provider | — | — | $31,518 | $0 |
| Patricia Bravo, Md, MD | Psychiatry | North Bay Village, FL | $31,369 | $0 |
| Thomas Montine, Md, MD | Anatomic Pathology & Clinical Pathology | Stanford, CA | $28,192 | $0 |
| Lale Kostakoglu Shields, Md, MD | Nuclear Radiology | Charlottesville, VA | $24,778 | $0 |
| Dr. Bartosz Rydzewski, Md, MD | Diagnostic Radiology | Louisville, KY | $22,025 | $0 |
| Dr. Alexander White, Md, MD | Family Medicine | Daytona Beach, FL | $19,670 | $0 |
| Dr. Alena Kreychman, Md, MD | Nuclear Radiology | Farmington, CT | $19,065 | $0 |
| Dr. Arun Basu, Md, MD | Diagnostic Radiology | Rochester, NY | $18,793 | $0 |
| Val Lowe, M.d, M.D | Nuclear Radiology | Rochester, MN | $16,529 | $0 |
| Brian Mccandless, Md, MD | Specialist | Clifton Park, NY | $14,312 | $0 |
| Dr. Peter Conti, M.d, M.D | Nuclear Radiology | Los Angeles, CA | $9,797 | $0 |
| Lon Schneider, Md, MD | Psychiatry | Los Angeles, CA | $9,782 | $0 |
| Stephen Salloway, Md, MD | Neurology | Providence, RI | $9,106 | $0 |
| Dr. Barry Siegel, Md, MD | Nuclear Radiology | Saint Louis, MO | $9,092 | $0 |
| David Wolk, Md, MD | Neurology | Philadelphia, PA | $7,726 | $0 |
About Avid Radiopharmaceuticals, Inc.
Avid Radiopharmaceuticals, Inc. has made $12.0M in payments to 111 healthcare providers, recorded across 676 transactions in the CMS Open Payments database. In 2024, the company paid $844,411. The top product by payment volume is AMYVID ($3.6M).
Payments were distributed across 22 medical specialties. The top specialty by payment amount is Diagnostic Radiology ($291,380 to 21 doctors).
Payment categories include: Food & Beverage ($5,978), Consulting ($344,197), Research ($11.6M), Travel & Lodging ($33,419).
Avid Radiopharmaceuticals, Inc. is associated with 1 products in the CMS Open Payments database.